Revision as of 23:15, 7 August 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'ChEBI').← Previous edit | Revision as of 23:28, 7 August 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified and watched fields - added verified revid - updated 'DrugBank_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_PharmacNext edit → | ||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| Verifiedfields = changed | |||
⚫ | | verifiedrevid = |
||
| Watchedfields = changed | |||
⚫ | | verifiedrevid = 414417007 | ||
| IUPAC_name = (2S)-2-propanoic acid | | IUPAC_name = (2S)-2-propanoic acid | ||
| image = Dexibuprofen Structural Formulae V.1.svg | | image = Dexibuprofen Structural Formulae V.1.svg | ||
Line 21: | Line 23: | ||
| ATC_prefix = M01 | | ATC_prefix = M01 | ||
| ATC_suffix = AE14 | | ATC_suffix = AE14 | ||
| ChEBI_Ref = {{ebicite|changed|EBI}} | |||
| ChEBI = 43415 | | ChEBI = 43415 | ||
| PubChem = 39912 | | PubChem = 39912 | ||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = | | DrugBank = | ||
| KEGG_Ref = {{keggcite|correct|kegg}} | | KEGG_Ref = {{keggcite|correct|kegg}} |
Revision as of 23:28, 7 August 2011
Pharmaceutical compoundClinical data | |
---|---|
Routes of administration | Oral, Other ROAs Unknown |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.106.960 |
Chemical and physical data | |
Formula | C13H18O2 |
Molar mass | 206.28082 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Dexibuprofen is a non-steroidal anti-inflammatory drug. It is the active dextrorotatory enantiomer of ibuprofen. Most ibuprofen formulations contain a racemic mixture of dexibuprofen and (−)-ibuprofen.
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines | |
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines | |
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |